🇺🇸 FDA
Pipeline program

Vidaza 25 mg/ml powder for suspension for injection, AG-120/S95031 250mg film-coated tablet, Placebo to Match AG-120 Tablet, 250 mg, is supplied as a film-coated tablet for oral administration.

AG120-C-009

Phase 3 small_molecule active

Quick answer

Vidaza 25 mg/ml powder for suspension for injection, AG-120/S95031 250mg film-coated tablet, Placebo to Match AG-120 Tablet, 250 mg, is supplied as a film-coated tablet for oral administration. for Previously Untreated Acute Myeloid Leukemia with an IDH1 Mutation is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Previously Untreated Acute Myeloid Leukemia with an IDH1 Mutation
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials